Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use

Authors
Category Primary study
JournalDrugs and Therapy Perspectives
Year 2024
This article has no abstract
Epistemonikos ID: fafdf643a4f7b511b7f452aa7b0f9b5c20f7d35b
First added on: Feb 17, 2025